BIOMAT Database Logo BIOMAT Database Logo

[Serum hyaluronidase activity of patients with acute dysentery]. 1977

E P Bespalov, and N I Pasternak

UI MeSH Term Description Entries
D004405 Dysentery, Bacillary DYSENTERY caused by gram-negative rod-shaped enteric bacteria (ENTEROBACTERIACEAE), most often by the genus SHIGELLA. Shigella dysentery, Shigellosis, is classified into subgroups according to syndrome severity and the infectious species. Group A: SHIGELLA DYSENTERIAE (severest); Group B: SHIGELLA FLEXNERI; Group C: SHIGELLA BOYDII; and Group D: SHIGELLA SONNEI (mildest). Shigellosis,Dysentery, Shiga bacillus,Dysentery, Shigella boydii,Dysentery, Shigella dysenteriae,Dysentery, Shigella dysenteriae type 1,Dysentery, Shigella flexneri,Dysentery, Shigella sonnei,Shigella Dysentery,Shigella Infection,Bacillary Dysentery,Dysenteries, Shigella,Dysenteries, Shigella boydii,Dysenteries, Shigella dysenteriae,Dysenteries, Shigella flexneri,Dysenteries, Shigella sonnei,Dysentery, Shigella,Infection, Shigella,Infections, Shigella,Shiga bacillus Dysentery,Shigella Dysenteries,Shigella Infections,Shigella boydii Dysenteries,Shigella boydii Dysentery,Shigella dysenteriae Dysenteries,Shigella dysenteriae Dysentery,Shigella flexneri Dysenteries,Shigella flexneri Dysentery,Shigella sonnei Dysenteries,Shigella sonnei Dysentery
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006821 Hyaluronoglucosaminidase An enzyme that catalyzes the random hydrolysis of 1,4-linkages between N-acetyl-beta-D-glucosamine and D-glucuronate residues in hyaluronate. (From Enzyme Nomenclature, 1992) There has been use as ANTINEOPLASTIC AGENTS to limit NEOPLASM METASTASIS. Hyaluronidase,Duran-Reynals Permeability Factor,GL Enzyme,Hyaglosidase,Hyaluronate Hydrolase,Wydase,Duran Reynals Permeability Factor,Factor, Duran-Reynals Permeability,Hydrolase, Hyaluronate,Permeability Factor, Duran-Reynals

Related Publications

E P Bespalov, and N I Pasternak
Hyaluronidase activity in serum of patients with complicated atherosclerosis.
January 1976, Acta medica Polona,
E P Bespalov, and N I Pasternak
Hyaluronidase activity in serum of patients with monoclonal gammapathy.
November 2000, Clinica chimica acta; international journal of clinical chemistry,
E P Bespalov, and N I Pasternak
Host-tumor relationship. XXXIV. Hyaluronidase activity and hyaluronidase inhibitor in the serum of patients with malignant tumors.
January 1977, Neoplasma,
E P Bespalov, and N I Pasternak
[Activity of serum cholinesterase and catalase in patients with typhoid and dysentery].
January 1967, Vrachebnoe delo,
E P Bespalov, and N I Pasternak
Serum Agglutination and Acute Dysentery.
January 1903, The Indian medical gazette,
E P Bespalov, and N I Pasternak
[Serum proteins in acute dysentery].
April 1958, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
E P Bespalov, and N I Pasternak
[Comparative determination of lymphocyte functional activity and serum O-antibody titers in acute dysentery patients].
February 1984, Klinicheskaia meditsina,
E P Bespalov, and N I Pasternak
[Treatment of patients with acute dysentery].
January 1979, Fel'dsher i akusherka,
E P Bespalov, and N I Pasternak
[Changes in serum hyaluronidase activity in patients with infiltrative-pneumonic pulmonary tuberculosis].
January 1971, Problemy tuberkuleza,
E P Bespalov, and N I Pasternak
Antipneumococcus hyaluronidase activity in human serum.
January 1945, Proceedings [of the] annual meeting. Central Society for Clinical Research (U.S.),
Copied contents to your clipboard!